It seems that all players in the healthcare arena need outcomes data - so why not work together? Glaxo Wellcome and QualMed Health Plan*have done just that, joining forces to assess the outcomes of sumatriptan use among health plan members. At the 1996 Congress on Health Outcomes & Accountability [Washington DC, US; December 1995], delegates heard how the 2 parties formed a successful partnership to gain the outcomes data they each required.